98%
921
2 minutes
20
Background: The neural mechanisms underlying aggressive behavior in schizophrenia (SCZ) remain poorly understood. To date, no studies have reported on the event-related potential (ERP) characteristics of aggression in SCZ using the competitive reaction time task (CRTT). Further investigation into the ERP correlates of aggression in SCZ would provide valuable insights into the neural processes involved.
Aim: To explore the neural mechanism of aggressive behavior in SCZ.
Methods: Participants of this study included 40 SCZ patients and 42 healthy controls (HCs). The Reactive Proactive Aggression Questionnaire was used to assess trait of aggression. The Barratt Impulsiveness Scale 11 was used to measure impulsiveness. The Positive and Negative Symptom Scale (PANSS) was used to evaluate psychopathological features and disease severity. All participants were measured with ERP while performing the CRTT. Data of behavior, ERP components (P2, N2, and P3), and feedback-related negativity (FRN) were analyzed.
Results: Analysis of the behavioral data revealed that compared with HCs, SCZ patients exhibited higher punishment choices. Analysis of ERP components showed that compared with HCs, SCZ patients exhibited higher N2 amplitudes and P2 amplitudes during the decision phase of the CRTT; however, SCZ patients exhibited lower FRN amplitudes and lower P3 amplitudes during the outcome phase of the CRTT. The N2 amplitudes evoked by high-intensity provocation were positively related to PANSS-P scores. And the P3 amplitudes evoked in the winning trials were negatively correlated with the PANSS-G scores.
Conclusion: SCZ patients exhibit abnormal ERP characteristics evoked by the CRTT, which suggests the neural correlates of aggressive behavior in SCZ.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12362632 | PMC |
http://dx.doi.org/10.5498/wjp.v15.i8.109280 | DOI Listing |
Schizophr Res
September 2025
Tianjin Anding Hospital, Mental Health Center, Tianjin Medical University, Tianjin, China. Electronic address:
Background: The relationship between age of onset and social cognition in schizophrenia (SCZ), as well as the role of peripheral plasma protein markers in this connection, remains unclear. This study aims to investigate these associations in first-episode drug-naïve SCZ.
Methods: A total of 171 SCZ patients were enrolled and categorized into non-late-onset and late-onset groups based on their age of onset, which was recorded at enrollment.
Adv Sci (Weinh)
September 2025
Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Key Laboratory of Mental Health of the Ministry of Education, Guangdong-Hong Kong-Macao Greater Bay Area Center for Brain Science and Brain-Inspired Intelligence, Guangdong-Hong Kong Joint Laboratory for Psychiatric Diso
Schizophrenia (SCZ) and bipolar disorder (BPD) are highly heritable psychiatric disorders with complex genetic and environmental underpinnings. Allele-specific expression (ASE) has emerged as a critical mechanism linking noncoding genetic variants to disease risk through epigenetic and environmental modulation. Here, whole-genome and transcriptome analyses of monozygotic twin pairs discordant for BPD or SCZ are performed, identifying that noncoding genetic variants drive differential ASE patterns of long noncoding RNAs (lncRNAs) in affected individuals compared to their unaffected co-twins.
View Article and Find Full Text PDFNeuroscience
September 2025
Institute of Physiology of the Czech Academy of Sciences, Videnska 1830, 14200 Prague 4, Czech Republic.
Impairments in decision-making and behavioral flexibility in patients with schizophrenia (SCZ) are currently among the most investigated aspects of SCZ. Increased GLUergic excitatory activity and decreased GABAergic inhibitory activity induce mPFC-vHPC γ/θ band desynchronization in many tasks where behavioral flexibility is tested. However, these tasks used "perceptual" decision-making/flexibility but not navigational decision-making/flexibility.
View Article and Find Full Text PDFJAMA Psychiatry
September 2025
Department of Psychiatry and Psychotherapy, Charité - Universitätsmedizin Berlin, Campus Mitte, Berlin, Germany.
Importance: Lithium augmentation is an effective treatment for patients with major depression after inadequate antidepressant response, but therapeutic outcomes vary considerably between individuals. Molecular studies may provide novel insights into treatment prediction and guide personalized therapy.
Objective: To investigate the association of polygenic risk scores (PRS) for schizophrenia (SCZ), major depressive disorder (MDD), and bipolar disorder (BIP) with clinical outcomes after lithium augmentation.
Schizophr Bull Open
January 2025
Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19063, United States.
Background: This paper focuses on the baseline clinical characterization of the participants in the Accelerating Medicines Partnership Schizophrenia (AMP SCZ) program. The AMP SCZ program is designed to investigate a wide array of clinical variables and biomarkers in a total of 2040 clinical high-risk (CHR) participants and 652 community control (CC) participants.
Methods: The dataset analyzed includes 1642 individuals at clinical high risk for psychosis and 519 CCs.